1. Home
  2. LADR vs EVO Comparison

LADR vs EVO Comparison

Compare LADR & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LADR
  • EVO
  • Stock Information
  • Founded
  • LADR 2008
  • EVO 1993
  • Country
  • LADR United States
  • EVO Germany
  • Employees
  • LADR N/A
  • EVO N/A
  • Industry
  • LADR Real Estate Investment Trusts
  • EVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • LADR Real Estate
  • EVO Health Care
  • Exchange
  • LADR Nasdaq
  • EVO Nasdaq
  • Market Cap
  • LADR 1.5B
  • EVO 1.6B
  • IPO Year
  • LADR 2014
  • EVO 2021
  • Fundamental
  • Price
  • LADR $11.40
  • EVO $3.41
  • Analyst Decision
  • LADR Buy
  • EVO Buy
  • Analyst Count
  • LADR 6
  • EVO 2
  • Target Price
  • LADR $13.29
  • EVO $5.90
  • AVG Volume (30 Days)
  • LADR 476.2K
  • EVO 65.8K
  • Earning Date
  • LADR 04-24-2025
  • EVO 04-23-2025
  • Dividend Yield
  • LADR 7.99%
  • EVO N/A
  • EPS Growth
  • LADR 6.17
  • EVO N/A
  • EPS
  • LADR 0.86
  • EVO N/A
  • Revenue
  • LADR $271,184,000.00
  • EVO $866,665,179.00
  • Revenue This Year
  • LADR N/A
  • EVO $3.70
  • Revenue Next Year
  • LADR $8.48
  • EVO $10.32
  • P/E Ratio
  • LADR $13.38
  • EVO N/A
  • Revenue Growth
  • LADR 6.98
  • EVO N/A
  • 52 Week Low
  • LADR $10.21
  • EVO $2.85
  • 52 Week High
  • LADR $12.48
  • EVO $7.98
  • Technical
  • Relative Strength Index (RSI)
  • LADR 43.37
  • EVO 23.36
  • Support Level
  • LADR $11.50
  • EVO $3.79
  • Resistance Level
  • LADR $11.88
  • EVO $3.56
  • Average True Range (ATR)
  • LADR 0.21
  • EVO 0.13
  • MACD
  • LADR -0.04
  • EVO -0.09
  • Stochastic Oscillator
  • LADR 9.26
  • EVO 1.64

About LADR Ladder Capital Corp

Ladder Capital Corp is an internally-managed real estate investment trust that is in commercial real estate finance. The company originates and invests in a diverse portfolio of commercial real estate and real estate-related assets, focusing on senior secured assets. The company's investment activities include: (i) Primary business of originating senior first mortgage fixed and floating rate loans collateralized by commercial real estate with flexible loan structures; (ii) owning and operating commercial real estate, including net leased commercial properties; and (iii) investing in investment-grade securities secured by first mortgage loans on commercial real estate. The company has three reportable segments include loans: which derives maximum profit; securities; and real estate.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: